Elanco

Update in progress

ELAN (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Elanco Animal Health develops, manufactures, and markets pet and farm animal health products worldwide. For pets, it offers parasiticides, vaccines, and therapeutics under brands such as Seresto, K-9 Advantage, Advantix, Advocate, Credelio, Interceptor Plus, Drontal, Galliprant, Atopica, Milbemax, Onsior, and TruFamily. For farm animals, it provides medicated feeds, injectables, vaccines, insecticides, and enzymes under brands like Rumensin, Baytril, Experior, Maxiban, Monteban, AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax. Sold via distributors, retailers, and directly to producers and veterinarians. Founded 1954, based in Indianapolis.

Company score

Sentiment: 0.90; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.43; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.51; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.75; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.14; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.52; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive